Dual-Targeting CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal Adenocarcinoma
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Pancreatic Ductal Adenocarcinoma (PDAC) · Unresectable Locally Advanced or Metastatic Disease
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Peking University Shenzhen Hospital, Shenzhen, Guangdong, China